AI Pharma Solutions
Act beyond human and experimental limitations. Knowledge to advance game-changing therapies from idea to market. The world's biomedical knowledge at your fingertips. Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are data-intensive and experimentally inaccessible. Molecular Health Dataome Technology offers powerful solutions to transform drug development. By merging world-class biomedical data, AI-powered analytics, and subject matter expertise, we deliver insights that go beyond human and experimental limitations.
Accelerate drug development and reduce costs by exploring in depth the complete data and information landscape around your product.
- Understand the biology of complex disease and identify better target-disease relationships
- Investigate molecular disease subtypes to identify and address responder patient populations
- Reveal new promising targets for the development of novel therapies
- Augment the value of pipeline drug candidates and portfolio drugs
- Optimize clinical trial structure, size, and relevant study cohorts
- Anticipate risks and mitigate failure of candidates at clinical stage
Eliminate bottlenecks in drug development and create new opportunities to expand the uses of approved drugs or drug candidates.
Through proprietary text-mining and integration of data from multiple global sources, Dataome Technology assimilates and structures an unparalleled body of information that is then organized into a highly interconnected knowledgebase of expert-curated quality. Those data can then be interrogated via a unique portfolio of analytical technologies and AI methods.